Regeneron Pharmaceuticals Inc. Common Stock.
NASDAQ-100727.70 1.29%
1M0.00% 1Y -0.00%  Analysts Review about Regeneron Pharmaceuticals Inc. Common Stock
Market Consensus (11 Analysts)
Strong Buy
Price Target High $923.83
Spread: 28.59%
Price Target Average $888.30
Spread: 23.65%
Price Target Low $682.89
Spread: -4.95%
Technical Analyses Trend
Periods
Trend
Resistance
Support
Short Term
Bearish
943.12 (29.60%)
906.00 (24.50%)
Mid Term
Bearish
988.25 (35.80%)
906.00 (24.50%)
Long Term
Bearish
988.25 (35.80%)
697.33 (-4.17%)
- 1W
- 1M
- 1Y
Regeneron Pharmaceuticals Inc. Common Stock Articles
The Motley Fool
Prediction: These 6 AI Stocks Will Be Worth a Combined $20 Trillion by 2030
The top six AI stocks are currently worth a combined $9.5 trillion. They could reach $20 trillion or more by 2030 via different paths, with AI serving as a key tailwind.
Sentiment: Positive 2023-05-30
Proactive Investors
Sirius Real Estate completes early refinancing of debt
Sirius Real Estate said it completed the early refinancing of its €58.3mln debt facility with Deutsche Pfandbriefbank seven months before the due date. A statement from the owner and operator of business and industrial parks said the refinancing comprises a seven-year €58.3mln facility with a fixed interest rate of 4.25%.
Sentiment: Positive 2023-05-30
Zacks Investment Research
Loan Growth Supports M&T Bank (MTB) Despite Rising Costs
M&T Bank's (MTB) top line gets support from increasing loan and deposit balances. Continued rising expenses keep the bottom line under pressure, while worsening credit quality is worrisome.
Sentiment: Negative 2023-05-30
S&P Stocks Review about Regeneron Pharmaceuticals Inc. Common Stock
SPS Rank 577th
SPS Rate 4
SPS Consensus (08 Analysts) Hold
Target Price 821.32 USD 12.87%
Potentials Excellent
Growth (Revenue) Extremely Poor
Finances Very Good
Profitability Excellent
Earnings Quality Fair
P/E Ratio Very Good
Valuation Overvalued
Fair Value 276.40USD -62.02%
Source
Sentiment
Za
Positive
Se
Positive
Ma
Negative
In
Positive
In
Positive
In
Positive
Se
Positive
2023-05-29 Buy 8 May Buffett Dividend Dogs And Watch 7
Se
Positive
Regeneron Pharmaceuticals Inc. Common Stock Overview 30 Nov 2020
Open 722.57
High 730.19
Low 720.19
1 Day Change (Last) 9.28
1 Day Change Percent (Last) 1.29%
Close 727.70
Previous Close 718.42
Volume 152,498
52 Week High 837.55
52 Week low 563.82
Gross Margin % 87.18%
Net Profit Margin % 35.64%
Total Shares Outstanding 107.89M
Market Capitalization 80.60B
Regeneron Pharmaceuticals Inc. Common Stock Weight (REGN) 0.04%
Dividends
Dividends Paid (Last Quarter) No Dividends
Dividends Paid (Last Fiscal Year)No Dividends
Dividends Per Share (Last Quarter) No Dividends
Dividends Yield (Last Fiscal Year) No Dividends
Dividends Per Share (Last Fiscal Year) No Dividends
Income Statement
Net Income (Last Fiscal Year) 4.34B
1 year Revenue12.17B
Last Quarter Revenue3.29B
4 months EPS revision 34.99